 | |
| Clinical data | |
|---|---|
| Other names | α-PHPP; alpha-PHPP; alpha-Pyrrolidinoheptiophenone; alpha-Pyrrolidinoheptanophenone; PV-8; PV8; Aphpp; A-PHPP |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C17H25NO |
| Molar mass | 259.393 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
α-Pyrrolidinoheptaphenone (PV8, α-PEP, α-PHPP, Aphpp, A-PHPP) is a designer drug of the pyrrolidinophenone class of cathinones.[1][2] It is the higher homolog of α-pyrrolidinohexiophenone (α-PHP).
In the United States, α-pyrrolidinoheptaphenone is a Schedule I Controlled Substance.[3]
See also
References
- ^ Minakata K, Yamagishi I, Nozawa H, Hasegawa K, Wurita A, Gonmori K, et al. (2015). "Determination of new pyrrolidino cathinone derivatives, PVT, F-PVP, MPHP, PV8, PV9 and F-PV9, in human blood by MALDI-Q-TOF mass spectrometry". Forensic Toxicology. 33: 148–154. doi:10.1007/s11419-014-0248-3. S2CID 8271553.
- ^ Uchiyama N, Matsuda S, Kawamura M, Shimokawa Y, Kikura-Hanajiri R, Aritake K, et al. (October 2014). "Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products". Forensic Science International. 243: 1–13. doi:10.1016/j.forsciint.2014.03.013. PMID 24769262.
- ^ "Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, α-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-α-PVP in Schedule I". Drug Enforcement Administration. Archived from the original on 2021-04-30. Retrieved 2019-07-30.
This page was last edited on 24 March 2024, at 14:27